Literature DB >> 30506647

E4F1 silencing inhibits the cell growth through cell-cycle arrest in malignant transformed cells induced by hydroquinone.

Qiang Tan1, Jieyou Li2,3, Jianming Peng4, Zhidong Liu4, Jiaxian Liu2, Haiqiao Zhang2, Qian Yuan2, Zhijie Pan2, Linhua Liu2,5.   

Abstract

Hydroquinone (HQ), one of the most significant metabolic activation products of benzene in an organism, can cause hematological toxicity, such as acute myeloid leukemia. It is a clear carcinogen that can cause changes in the disorder of cell cycle and cell growth. However, its molecular mechanisms remain unclear. E4 transcription factor 1 (E4F1), an important transcription factor, participating in the regulation of cell cycle may be related to the occurrence of tumor. Here, we examined the HQ-induced malignant transformed TK6 cells (TK6-HT) to illustrate the role of E4F1 in carcinogenesis. The present study showed that both the expressions of E4F1 messenger RNA and protein increased obviously in TK6-HT, preliminarily indicating that E4F1 is associated with HQ-induced carcinogenesis. To further explore the role of E4F1, we established E4F1 silencing TK6-HT (pLVX-shE4F1) and its control cells (pLVX-shNC) using lentiviral short hairpin RNA (shRNA) interference expression plasmid vector pLVX-shRNA. Flow cytometry and cell counting kit-8 assay were used to determine the effects of E4F1 silencing on cell cycle and cell growth, respectively. E4F1 silencing inhibited cell growth in TK6-HT. The results from flow cytometry indicated that the inhibitory effect on cell growth may be the results of the E4F1 silencing-induced accumulation in G2/M compared with TK6-HT-shNC. Meanwhile, levels of DNA damage (γ-H2AX), proteins of Rb and phosphorylated Rb, and reactive oxygen species were increased in TK6-HT-shRNA2 cells, which is the critical reason of cell-cycle arrest. In conclusion, E4F1 silencing inhibits the cell growth through cell-cycle arrest in malignant transformed cells induced by HQ.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  E4 transcription factor 1 (E4F1); cell cycle; cell growth; hydroquinone (HQ); malignant transformation

Mesh:

Substances:

Year:  2018        PMID: 30506647     DOI: 10.1002/jbt.22269

Source DB:  PubMed          Journal:  J Biochem Mol Toxicol        ISSN: 1095-6670            Impact factor:   3.642


  4 in total

1.  Immunomodulatory Effects of Vitamin D Supplementation in a Deficient Population.

Authors:  Mathieu Garand; Mohammed Toufiq; Parul Singh; Susie Shih Yin Huang; Sara Tomei; Rebecca Mathew; Valentina Mattei; Mariam Al Wakeel; Elham Sharif; Souhaila Al Khodor
Journal:  Int J Mol Sci       Date:  2021-05-10       Impact factor: 5.923

Review 2.  New Insights into LINC00346 and its Role in Disease.

Authors:  Juan Lu; Zhaoying Xiao; Mengqiu Xu; Lanjuan Li
Journal:  Front Cell Dev Biol       Date:  2022-01-13

3.  Identification of potential pathways and microRNA-mRNA networks associated with benzene metabolite hydroquinone-induced hematotoxicity in human leukemia K562 cells.

Authors:  Chun-Hong Yu; Shui-Qing Yang; Lei Li; Yu Xin; Fang Zhang; Xiao-Fan Liu; Zong-Chun Yi
Journal:  BMC Pharmacol Toxicol       Date:  2022-04-02       Impact factor: 2.483

4.  Multi-Level Control of the ATM/ATR-CHK1 Axis by the Transcription Factor E4F1 in Triple-Negative Breast Cancer.

Authors:  Kalil Batnini; Thibault Houles; Olivier Kirsh; Stanislas Du Manoir; Mehdi Zaroual; Hélène Delpech; Chloé Fallet; Matthieu Lacroix; Laurent Le Cam; Charles Theillet; Claude Sardet; Geneviève Rodier
Journal:  Int J Mol Sci       Date:  2022-08-16       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.